We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

52 hedge funds and large institutions have $92.7M invested in AVEO Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $3.37M | Put options by funds: $2.32M

0% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 14

1% less capital invested

Capital invested by funds: $94M → $92.7M (-$1.29M)

17% less funds holding

Funds holding: 63 → 52 (-11)

48% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 23

Holders
52
Holders Change
-11
Holders Change %
-17.46%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
14
Reduced
14
Closed
23
Calls
$3.37M
Puts
$2.32M
Net Calls
+$1.05M
Net Calls Change
+$366K

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$11.9M
2
WVP
Worth Venture Partners
New Jersey
+$2.72M
3
Millennium Management
Millennium Management
New York
+$1.32M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$940K
5
BGIM
Brandywine Global Investment Management
Pennsylvania
+$775K

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$5.89M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.48M
3
Two Sigma Investments
Two Sigma Investments
New York
-$1.4M
4
MS
Maven Securities
Jersey
-$1.27M
5
OM
Opaleye Management
Massachusetts
-$1.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
26
Evercore Wealth Management
New York
$259K +$2.98K +498 +1%
BC
27
Birchview Capital
Vermont
$247K +$239K +40,000 New
Group One Trading
28
Group One Trading
Illinois
$244K -$58.7K -9,809 -20%
GCP
29
GSA Capital Partners
United Kingdom
$218K +$211K +35,232 New
CSS
30
Cubist Systematic Strategies
Connecticut
$207K +$201K +33,548 New
Simplex Trading
31
Simplex Trading
Illinois
$168K +$161 +27 +0.1%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$146K -$27.9K -4,662 -16%
PCS
33
Personal CFO Solutions
New Jersey
$142K – – –
GC
34
Grimes & Company
Massachusetts
$134K +$129K +21,640 New
Charles Schwab
35
Charles Schwab
California
$107K +$103K +17,180 New
Connor, Clark & Lunn Investment Management (CC&L)
36
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$91K +$88.2K +14,742 New
Bank of New York Mellon
37
Bank of New York Mellon
New York
$78K -$48K -8,020 -39%
MOS
38
MGO One Seven
Ohio
$68K – – –
VF
39
Virtu Financial
New York
$64K +$61.9K +10,342 New
TRCT
40
Tower Research Capital (TRC)
New York
$20K -$153K -25,629 -89%
Wells Fargo
41
Wells Fargo
California
$14K -$6 -1 -0%
Osaic Holdings
42
Osaic Holdings
Arizona
$11K -$150 -25 -2%
EWM
43
Edge Wealth Management
New York
$6K – – –
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$5K -$17.2K -2,876 -78%
WIM
45
Westside Investment Management
California
$3.13K – – –
LFG
46
Larson Financial Group
Missouri
$3K – – –
GSWM
47
Golden State Wealth Management
California
$3K +$2.99K +500 New
TFGT
48
TS Financial Group (TSFG)
Illinois
$2K – – –
AF
49
Advisornet Financial
Minnesota
$1K – – –
JP Morgan Chase
50
JP Morgan Chase
New York
$1K – – –
1
2
3

AVEO Hedge Fund Activity: Q3 2021 in Review

52 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q3 2021, worth a combined $92.7M — down 1.4% from $94M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of AVEO and 12 opened new positions — a net loss of 11 holders — while 14 trimmed existing stakes and 14 added.

The largest buyer was AIGH Capital Management, opening a new position worth an estimated $11.9M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $5.89M sold.

  • 52 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q3 2021, down from 63 in Q2 2021.
  • Funds reported $92.7M of AVEO Pharmaceuticals, Inc. stock for Q3 2021, down 1.4% quarter-over-quarter.
  • 12 funds opened new AVEO Pharmaceuticals, Inc. positions in Q3 2021 and 23 closed out, a net change of -11 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q3 2021 was AIGH Capital Management, an estimated $11.9M added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q3 2021 was Cormorant Asset Management, an estimated $5.89M sold.

Based on aggregated 13F filings for Q3 2021.